Vimarsana
Biggest News Aggregation in the World

Trial Background News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trial Background. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trial Background Today - Breaking & Trending Today

Theseus Pharmaceuticals Reports Initial Dose Escalation Data from Ongoing Phase 1/2 Trial of THE-630 in Patients with Advanced GIST - Vimarsana News

Theseus Pharmaceuticals Reports Initial Dose Escalation Data from Ongoing Phase 1/2 Trial of THE-630 in Patients with Advanced GIST

-- THE-630 demonstrates encouraging safety profile through Cohort 6 , supportive of continued dose escalation -- -- Dose-dependent reductions observed in ctDNA KIT-mutant allele fractions for both... | May 25, 2023

Theseus Pharmaceuticals Reports Initial Dose Escalation Data from Ongoing Phase 1/2 Trial of THE-630 in Patients with Advanced GIST - Vimarsana News

Theseus Pharmaceuticals Reports Initial Dose Escalation Data from Ongoing Phase 1/2 Trial of THE-630 in Patients with Advanced GIST

-- THE-630 demonstrates encouraging safety profile through Cohort 6 (18 mg), supportive of continued dose escalation -- -- Dose-dependent reductions observed...

Kinnate Biopharma : Results of Operations and Financial Condition - Form 8-K - Vimarsana News

Kinnate Biopharma : Results of Operations and Financial Condition - Form 8-K

First Report of Positive Dose Escalation Data Supports Best-in-Class Profile for Investigational Exarafenib as a... | April 17, 2023